Desktop Site
|
29 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
*
Notices
|
S&P
BSE SENSEX
74,671.28
+941.12
+1.28 %
Corporate Announcement
Security Code
526139
Company
TRANSGENE BIOTEK LTD.
Exchange Received Time
14/02/2024 11:53:43
Exchange Disseminated Time
14/02/2024 11:53:45
Time Taken
00:00:02
Board Meeting Outcome for Outcome Of Board Meeting |
2/14/2024 11:53:45 AM
1) The Board has considered and approved the unaudited Consolidated & Stand-alone Financial Results of the company, for the Quarter ended 31.12.2023 in accordance with the Indian Accounting Standards (IND-AS) as per Companies (Indian Accounting Standards) Rules, 2015. 2) Limited Review Report on the Unaudited Standalone and Consolidated Financial Results of the Company, for the quarter ended 31.12.2023 has also been approved.
Attachment
<< Back
Recently Viewed